The customer observed falsely elevated ca19-9 results on the architect i2000sr analyzer.The following data was provided: initial 7900.63, repeated on another sample 193.25, repeat 188.49 u/ml.There was no impact to patient management reported.No further patient details or diagnosis could be obtained.
|
Further investigation of the customer issue included a review of the complaint text, a search for similar complaints, review of instrument logs, a review of labeling and accuracy testing.No adverse trend was identified for the customer's issue.Labeling was reviewed and found to be adequate.Accuracy testing met all specifications.Based on all available information and abbott diagnostics' complaint investigation, the assay performed as intended and no product deficiency was identified.
|